Blog
RSS FeedPosted by Michael Wonder on 09 Oct 2023
SMC - October 2023 decisions
9 October 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
Posted by Michael Wonder on 11 Sep 2023
SMC - September 2023 decisions
11 September 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
Posted by Michael Wonder on 07 Aug 2023
Scottish Medicines Consortium accepts Vazkepa (icosapent ethyl) to help reduce cardiovascular risk for patients in Scotland
7 August 2023 - Vazkepa already commercially available in England, Wales, and Northern Ireland where NICE recommended its reimbursement and use ...
Posted by Michael Wonder on 07 Aug 2023
SMC - August 2023 decisions
7 August 2023 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 10 Jul 2023
SMC - July 2023 decisions
10 July 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
Posted by Michael Wonder on 13 Jun 2023
SMC accepts Rinvoq (upadacitinib) as a treatment option for adults with moderately to severely active Crohn’s disease in Scotland
12 June 2023 - The SMC decision is supported by data from three Phase 3 clinical trials demonstrating upadacitinib achieved ...
Posted by Michael Wonder on 12 Jun 2023
SMC - June 2023 decisions
12 June 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
Posted by Michael Wonder on 09 May 2023
SMC - May 2023 decisions
9 May 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
Posted by Michael Wonder on 14 Feb 2023
Scotland becomes first part of UK to approve new cervical cancer drug
13 February 2023 - The SMC has approved the use of the drug pembrolizumab – which is also known as ...
Posted by Michael Wonder on 13 Feb 2023
SMC - February 2023 decisions
13 February 2023 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
Posted by Michael Wonder on 16 Jan 2023
SMC - January 2023 decisions
16 January 2023 - The Scottish Medicines Consortium, which advises on newly-licensed medicines for use by NHSScotland, has today published ...
Posted by Michael Wonder on 11 Oct 2022
Scotland backs three new uses for MSD’s Keytruda
11 October 2022 - Scotland has become the first country in the UK to back NHS funding for the use ...
Posted by Michael Wonder on 10 Oct 2022
SMC - October 2022 decisions
10 October 2022 - The SMC has today published advice on new medicines for six different conditions. ...
Posted by Michael Wonder on 14 Sep 2022
Jazz Pharmaceuticals receives SMC approval for reimbursement of Sativex
14 September 2022 - Therapy is for the treatment of spasticity due to multiple sclerosis. ...
Posted by Michael Wonder on 13 Sep 2022
Prostate cancer symptoms as new treatment given green light in Scotland
13 September 2022 - A new treatment for advanced prostate cancer has been approved for use in Scotland, giving medical ...